The proteostasis boundary in misfolding diseases of membrane traffic.
Protein function is regulated by the proteostasis network (PN) [Balch, W.E., Morimoto, R.I., Dillin, A. and Kelly, J.W. (2008) Adapting proteostasis for disease intervention. Science 319, 916-919], an integrated biological system that generates and protects the protein fold. The composition of the PN is regulated by signaling pathways including the unfolded protein response (UPR), the heat-shock response (HSR), the ubiquitin proteasome system (UPS) and epigenetic programs. Mismanagement of protein folding and function during membrane trafficking through the exocytic and endocytic pathways of eukaryotic cells by the PN is responsible for a wide range of diseases that include, among others, lysosomal storage diseases, myelination diseases, cystic fibrosis, systemic amyloidoses such as light chain myeloma, and neurodegenerative diseases including Alzheimer's. Toxicity from misfolding can be cell autonomous (affect the producing cell) or cell non-autonomous (affect a non-producing cell) or both, and have either a loss-of-function or gain-of-toxic function phenotype. Herein, we review the role of the PN and its regulatory transcriptional circuitry likely to be operational in managing the protein fold and function during membrane trafficking. We emphasize the enabling principle of a 'proteostasis boundary (PB)' [Powers, E.T., Morimoto, R.T., Dillin, A., Kelly, J.W., and Balch, W.E. (2009) Biochemical and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959-991]. The PB is defined by the combined effects of the kinetics and thermodynamics of folding and the kinetics of misfolding, which are linked to the variable and adjustable PN capacity found different cell types. Differences in the PN account for the versatility of protein folding and function in health, and the cellular and tissue response to mutation and environmental challenges in disease. We discuss how manipulation of the folding energetics or the PB through metabolites and pharmacological intervention provides multiple routes for restoration of biological function in trafficking disease.
Hutt
Darren M
DM
Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. dhutt@scripps.edu
Powers
Evan T
ET
Balch
William E
WE
D002462:Cell Membrane / Q000378:metabolism*; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy / Q000378:metabolism*; D053858:Metabolic Networks and Pathways; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000378:metabolism*; D017510:Protein Folding; D021381:Protein Transport; D011506:Proteins / Q000378:metabolism*
D011506:Proteins
Annu Rev Pathol. 2008;3:427-55
18039129
Curr Mol Med. 2008 May;8(3):157-72
18473817
Endocr Rev. 2008 May;29(3):303-16
18314421
J Clin Invest. 2005 May;115(5):1111-9
15864338
Pharmacol Rev. 2007 Sep;59(3):225-50
17878512
Nature. 2007 Nov 29;450(7170):712-6
18046409
Nature. 2006 Dec 14;444(7121):860-7
17167474
Semin Cell Dev Biol. 2007 Dec;18(6):716-31
18023214
EMBO J. 2005 Dec 7;24(23):4124-32
16281052
Cell Calcium. 2005 Sep-Oct;38(3-4):303-10
16076486
Annu Rev Biochem. 2009;78:959-91
19298183
Mol Biol Cell. 2005 Aug;16(8):3847-64
15944222
J Bioenerg Biomembr. 1997 Oct;29(5):483-90
9511933
Nature. 2008 Jul 24;454(7203):455-62
18650916
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3131-6
19204290
Annu Rev Pathol. 2008;3:399-425
18039139
Adv Drug Deliv Rev. 2007 Aug 10;59(8):759-81
17681635
FEBS J. 2007 Oct;274(19):4944-50
17894779
Nature. 2006 Dec 14;444(7121):854-9
17167473
Semin Cancer Biol. 2007 Oct;17(5):363-9
17555985
Cell. 2008 Jan 11;132(1):27-42
18191218
Diabetes Metab. 2008 Feb;34 Suppl 2:S91-5
18640591
Cell Mol Life Sci. 2008 Mar;65(6):855-61
18239856
J Mol Neurosci. 2006;30(3):249-65
17401151
Prog Retin Eye Res. 2008 Jul;27(4):434-49
18490186
Science. 2006 Aug 25;313(5790):1137-40
16931765
Cell. 2008 Sep 5;134(5):769-81
18775310
Biochem J. 2008 Mar 15;410(3):439-53
18290764
Nature. 2008 Jul 24;454(7203):428-35
18650913
Endocr Rev. 2008 May;29(3):367-79
18292465
Annu Rev Biochem. 2008;77:363-82
18410248
Science. 2008 May 9;320(5877):811-4
18467592
J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43
15292279
Biochemistry. 2008 Jul 1;47(26):6969-84
18537267
Science. 2008 Feb 15;319(5865):916-9
18276881
Cell. 2006 Nov 17;127(4):803-15
17110338
Biochim Biophys Acta. 2008 Apr;1783(4):535-48
18093543
Antioxid Redox Signal. 2007 Dec;9(12):2277-93
17979528
Science. 2006 Mar 10;311(5766):1471-4
16469881
Contrib Nephrol. 2007;153:195-210
17075231
Curr Opin Chem Biol. 2007 Aug;11(4):412-8
17644022
Ann N Y Acad Sci. 2007 Oct;1113:202-16
17513464
Neurosci Res. 2006 Dec;56(4):441-9
17028027
Cell. 2007 Nov 16;131(4):809-21
18022373
Nat Neurosci. 2009 Apr;12(4):379-85
19287390
Diabetes Obes Metab. 2007 Nov;9 Suppl 2:23-7
17919175
Endocr Rev. 2008 Feb;29(1):42-61
18048764
Adv Exp Med Biol. 2007;594:167-89
17205684
Ann Med. 2008;40(6):402-17
19160570
Genes Dev. 2007 Jan 15;21(2):195-205
17234885
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9849-50
18632571
Nature. 2006 Dec 14;444(7121):840-6
17167471
Pathophysiology. 2008 Aug;15(2):103-8
18599274
Nat Rev Mol Cell Biol. 2004 Oct;5(10):781-91
15459659
Nature. 2007 May 31;447(7144):550-5
17476212
Cell. 2005 Apr 8;121(1):73-85
15820680
J Lipid Res. 2007 Sep;48(9):1905-14
17699733
Curr Treat Options Oncol. 2000 Apr;1(1):83-9
12057064
Cell Calcium. 2005 Sep-Oct;38(3-4):161-9
16076488
Genes Dev. 2008 Jun 1;22(11):1427-38
18519635
Genome Res. 2008 Apr;18(4):644-52
18381899
Cell Mol Life Sci. 2004 Oct;61(19-20):2461-70
15526154
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18525-30
19011102
Endocr Rev. 2008 May;29(3):317-33
18436705
Curr Opin Investig Drugs. 2008 Apr;9(4):371-8
18393104
Front Biosci (Landmark Ed). 2009 Jan 01;14:973-94
19273112
J Intern Med. 2007 Jan;261(1):5-16
17222164
Cell Death Differ. 2009 Jan;16(1):39-45
18617899
BMC Biochem. 2007 Nov 22;8 Suppl 1:S11
18047735
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
17565364
Int Rev Cell Mol Biol. 2008;267:59-124
18544497
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90
17502601
Biochem J. 2008 Jul 1;413(1):29-36
18361776
Mol Endocrinol. 2008 Feb;22(2):477-84
17916655
Nat Rev Genet. 2009 Mar;10(3):173-83
19204719
Annu Rev Biophys. 2008;37:289-316
18573083
Trends Biochem Sci. 2007 Nov;32(11):520-8
17962019
Annu Rev Biochem. 2008;77:701-26
18304008